International Patent: COMPLEX FORMULATION FOR ORAL ADMINISTRATION COMPRISING SGLT-2 INHIBITOR AND METHOD FOR PREPARING SAME

GENEVA, July 2 -- DAEWOONG PHARMACEUTICAL CO., LTD. filed a patent application (KR2025/021716) for “COMPLEX FORMULATION FOR ORAL ADMINISTRATION COMPRISING SGLT-2 INHIBITOR AND METHOD FOR PREPARING SAME”. With publication no. WO/2026/135083, here are the other details related to the patent application:

Kind: Initial Publication with ISR [A1]

IPC: A61K 9/24

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Disclaimer: Curated by HT Syndication....